Tiziana Life Sciences (TILS)

 

TILS Share PerformanceMore

52 week high240.00 25/04/17
52 week low110.00 24/06/16
52 week change 47.75 (34.05%)
4 week volume140,184 27/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Financial Results for Year Ended 31 December 2016

RNS Number: 8921F Tiziana Life Sciences PLC 23 May 2017 Tiziana Life Sciences plc ("Tiziana" or "the Company") Financial Results for the Year Ended 31 December 2016 Strong progress continues across clinical and pre-clinical programmes London, 23 May 2017 - Tiziana Life Sciences plc ("Tiziana", AIM: TILS), a clinical stage biotechnology company developing ta...

Broker Forecast - Beaufort Securities issues a broker note on Tiziana Life Sciences Plc Ord 3p

Beaufort Securities today reaffirms its speculative buy investment rating on Tiziana Life Sciences Plc Ord 3p (LON:TILS) ...

TILS confirms Phase II clinical trial protocol for Milciclib

Tiziana Life Sciences has announced the approval in Israel of a phase II clinical trial protocol for testing milciclib, a novel ...

Announces Approval of a Phase II Clinical Trial

RNS Number: 0864D Tiziana Life Sciences PLC 24 April 2017 Tiziana Life Sciences plc ("Tiziana" or the "Company") Tiziana Life Sciences Announces Approval of a Phase II Clinical Trial Protocol for Milciclib in Patients with Hepatocellular Carcinoma In mouse models of HCC, oral administration with milciclib effectively suppressed tumour growth London, 24 A...

Announces Publication of Milciclib Clinical Trial

RNS Number: 9222C Tiziana Life Sciences PLC 21 April 2017 Tiziana Life Sciences plc ("Tiziana" or the "Company") Tiziana Life Sciences Announces Publication of Peer-Reviewed Paper from Positive Clinical Trial of Milciclib in Patients with Refractory Solid Tumours Encouraging data from phase I study published in Cancer Chemotherapy and Pharmacology L...

Tiziana Life Sciences notes exercise of warrants

Tiziana Life Sciences has received a notification from warrant holders to exercise warrants over 1.8m shares at an exercise...

Exercise of Warrants & Issue of Equity

RNS Number: 3990A Tiziana Life Sciences PLC 24 March 2017 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Exercise of Warrants & Issue of Equity London, 24 March 2017 - Tiziana Life Sciences plc (AIM: TILS, the "Company"), the clinical stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, announces ...

Arun Sanyal appointed to Scientific Advisory Board

RNS Number: 3208Z Tiziana Life Sciences PLC 14 March 2017 Tiziana Life Sciences PLC ("Tiziana" or the "Company") Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board Dr. Arun Sanyal is a distinguished professor and a key opinion leader in liver diseases such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepati...

Fundamental DataMore

EPS-9.5
Dividend yield0 %

Equity Research (TILS)

equity development
Tiziana Life Sciences PLC
26/01/2015
TILS has just announced an exclusive license with Nerviano Medical Sciences (NMS) for its Phase 2 anti-cancer drug candidate, milciclib. It helps block the rampant cell division associated with...
equity development
Tiziana Life Sciences PLC
12/01/2015
Tiziana (TILS) and Novimmune S.A., a company focused on the discovery and development of antibody-based drugs to benefit patients with inflammatory, auto-immune disorders, and cancer, have announced...
equity development
Tiziana Life Sciences PLC
30/09/2014
Tiziana Life Sciences (TILS) has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment,...

Latest discussion posts More

  • Fundraise

    Beaufort Securities's note out this morning on Research Tree: "Tiziana progressed well during the FY2015. It strengthened its portfolio by acquiring exclusive licence for both ...
    8-Jun-2016
    Simbr
  • no buying

    With sp @110 and bid @ 115 I tried buying 2500 online at Barclays. Quoted 187.4 Obviously buying is being discouraged for whatever reason
    28-Apr-2016
    osammyboy
  • More cheap shares for the boys. When can we get some?
    15-Jan-2016
    osammyboy

Users' HoldingsMore

Users who hold Tiziana Life Sciences also hold..
LENOVO62%
LLOYDS GRP.28%
ROYAL BANK SCOT20%
TAYLOR WIMPEY15%
BT GROUP13%

Codes & Symbols

ISINGB00BKWNZY55
SymbolsTILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS